Syndax Pharmaceuticals reported a gross margin of 83.35% and a net margin of -49.80% for the quarter ended Jun 2026. These financial ratios cover 45 quarters of results from Jun 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||||||||||||
| Gross Margin | 100.00% | 100.00% | 35.81% | 59.84% | 79.31% | 81.94% | 86.04% | 81.74% | 83.35% | ||||||||||||||||||||||||||||||||||||
| EBT Margin | -166.45% | 75.72% | -2,124.66% | -673.26% | -1,160.59% | -416.10% | -167.05% | -113.70% | -84.71% | -53.41% | -49.80% | ||||||||||||||||||||||||||||||||||
| EBIT Margin | -161.87% | 75.65% | -2,120.46% | -716.62% | -1,254.75% | -417.91% | -182.71% | -125.19% | -91.01% | -52.73% | -54.95% | ||||||||||||||||||||||||||||||||||
| EBITDA Margin | -161.87% | 75.65% | -2,120.46% | -716.62% | -1,254.75% | -417.91% | -182.71% | -125.19% | -91.01% | -52.73% | -54.95% | ||||||||||||||||||||||||||||||||||
| Operating Margin | -161.87% | 75.65% | -2,120.46% | -716.62% | -1,254.75% | -417.91% | -182.71% | -125.19% | -91.01% | -52.73% | -54.95% | ||||||||||||||||||||||||||||||||||
| Net Margin | -166.45% | 75.72% | -2,124.66% | -673.26% | -1,160.59% | -416.10% | -167.05% | -113.70% | -84.71% | -53.41% | -49.80% | ||||||||||||||||||||||||||||||||||
| FCF Margin | -201.57% | 79.56% | -2,047.00% | -498.58% | -747.24% | -474.81% | -231.30% | -154.05% | -101.19% | -77.62% | -41.59% | ||||||||||||||||||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 2.52M | 11.18M | 21.35M | 28.88M | 33.85M | 34.06M | |||||||||||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 251.28M | 344.58M | 435.94M | 414.33M | 383.06M | 428.46M | 478.53M | 445.58M | 415.28M | 506.05M | 577.95M | 509.99M | 451.38M | 575.31M | 682.76M | 618.43M | 573.97M | 540.75M | 501.19M | 588.16M | |||||||||||||||||||||||||
| Invested CapitalInvested Cap. | 219.48M | 428.45M | 394.60M | 382.15M | 338.10M | 467.45M | 554.20M | 631.80M | 544.70M | 481.84M | 436.42M | 408.54M | 385.59M | 359.12M | |||||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.05 | 0.41 | 0.31 | 0.33 | 0.25 | 0.01 | 0.04 | 0.04 | 0.06 | 0.13 | 0.19 | 0.32 | 0.43 | 0.43 | |||||||||||||||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -30.87 | -0.01M | -56.62 | -54.28 | -20.10 | -977.51 | -0.00M | -0.00M | -805.07 | -0.00M | -913.95 | -862.98 | -0.00M | 777.14 | -0.04M | -0.02M | -0.02M | ||||||||||||||||||||||||||||
| Debt Ratio | 0.09 | 0.04 | 0.05 | 0.05 | 0.47 | 0.51 | 0.54 | 0.58 | 0.65 | 0.73 | 0.49 | ||||||||||||||||||||||||||||||||||
| Times Interest Earned | -30.87 | -0.01M | -56.62 | -54.28 | -20.10 | -977.51 | -0.00M | -0.00M | -805.07 | -0.00M | -913.95 | -862.98 | -0.00M | 777.14 | -0.04M | -0.02M | -0.02M | ||||||||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -45.32 | 12.56 | -25.04 | -27.74 | -41.15 | -44.35 | -31.73 | -29.09 | -19.80 | -21.00 | -25.10 | -23.47 | -19.57 | -12.71 | -12.67 | -12.70 | -25.64 | -31.54 | -59.71 | -53.76 | |||||||||||||||||||||||||
| Price to SalesP/S | 75.44 | 9.51 | 498.75 | 131.78 | 147.51 | 52.72 | 21.22 | 29.16 | 26.72 | 31.89 | 26.77 | ||||||||||||||||||||||||||||||||||
| Price to BookP/B | 4.69 | 2.95 | 2.55 | 3.00 | 4.27 | 3.71 | 3.32 | 3.63 | 2.82 | 2.74 | 4.11 | 4.02 | 4.50 | 3.93 | 4.91 | 5.12 | 11.59 | 28.41 | 49.69 | 129.07 | |||||||||||||||||||||||||
| Enterprise Value | 703.70M | 981.39M | 558.39M | 718.22M | 1,106.79M | 1,257.63M | 1,014.23M | 1,054.39M | 647.59M | 950.02M | 1,587.94M | 1,320.54M | 1,257.64M | 560.00M | 544.46M | 350.28M | 901.49M | 1,442.33M | 1,716.32M | 1,400.97M | |||||||||||||||||||||||||
| EV to EBIT | -35.13 | 10.25 | -15.15 | -19.04 | -31.50 | -29.92 | -22.04 | -21.22 | -11.49 | -12.19 | -19.97 | -17.79 | -14.04 | -5.81 | -6.50 | -5.05 | -15.70 | -23.06 | -50.18 | -35.03 | |||||||||||||||||||||||||
| EV to EBITDA | -35.13 | 10.25 | -15.15 | -19.04 | -31.50 | -29.92 | -22.04 | -21.22 | -11.49 | -12.19 | -19.97 | -17.79 | -14.04 | -5.81 | -6.50 | -5.05 | -15.70 | -23.06 | -50.18 | -35.03 | |||||||||||||||||||||||||
| Market Capitalization | 933.53M | 1,203.58M | 956.44M | 1,085.13M | 1,444.75M | 1,733.43M | 1,446.62M | 1,453.19M | 1,011.15M | 1,520.72M | 2,022.52M | 1,745.64M | 1,647.25M | 1,132.88M | 1,056.66M | 805.51M | 1,337.47M | 1,836.40M | 2,068.39M | 1,948.83M | |||||||||||||||||||||||||
| Price to FCFP/FCF | -37.43 | 11.95 | -22.81 | -26.92 | -50.61 | -75.72 | -36.88 | -41.08 | -22.64 | -36.78 | -24.21 | -24.37 | -26.43 | -19.74 | -11.10 | -9.17 | -18.93 | -26.41 | -41.08 | -64.38 | |||||||||||||||||||||||||
| EV to FCF | -28.21 | 9.74 | -13.32 | -17.82 | -38.78 | -54.93 | -25.85 | -29.81 | -14.50 | -22.98 | -19.01 | -18.43 | -20.18 | -9.76 | -5.72 | -3.99 | -12.76 | -20.74 | -34.09 | -46.28 | |||||||||||||||||||||||||
| EV to CFO | -28.21 | 9.74 | -13.32 | -17.82 | -38.78 | -54.93 | -25.85 | -29.81 | -14.50 | -22.98 | -19.01 | -18.43 | -20.18 | -9.76 | -5.72 | -3.99 | -12.78 | -20.76 | -34.09 | -46.28 | |||||||||||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -161.87% | 75.65% | -124.07% | -139.68% | -181.67% | -2,120.46% | -716.62% | -1,254.75% | -417.91% | -182.71% | -125.19% | -91.01% | -52.73% | -54.95% | |||||||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -40.16% | 8.10% | 4.08% | 0.30% | -3.86% | -38.00% | -35.38% | -41.61% | -51.60% | -51.33% | -49.98% | -61.60% | -81.94% | -72.00% | -58.47% | -67.08% | -66.75% | -64.92% | -53.86% | -39.75% | |||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -36.50% | 7.11% | 3.23% | -0.50% | -4.33% | -35.36% | -33.20% | -38.09% | -44.72% | -43.28% | -43.95% | -54.60% | -69.01% | -57.05% | -48.49% | -51.76% | -50.19% | -47.56% | -41.59% | -30.82% |